Functional analysis of Hsp70 inhibitors.
The molecular chaperones of the Hsp70 family have been recognized as targets for anti-cancer therapy. Since several paralogs of Hsp70 proteins exist in cytosol, endoplasmic reticulum and mitochondria, we investigated which isoform needs to be down-regulated for reducing viability of cancer cells. Fo...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/61d0e4e74a9e4efa87d2fb910f1f8022 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:61d0e4e74a9e4efa87d2fb910f1f8022 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:61d0e4e74a9e4efa87d2fb910f1f80222021-11-18T08:47:09ZFunctional analysis of Hsp70 inhibitors.1932-620310.1371/journal.pone.0078443https://doaj.org/article/61d0e4e74a9e4efa87d2fb910f1f80222013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24265689/?tool=EBIhttps://doaj.org/toc/1932-6203The molecular chaperones of the Hsp70 family have been recognized as targets for anti-cancer therapy. Since several paralogs of Hsp70 proteins exist in cytosol, endoplasmic reticulum and mitochondria, we investigated which isoform needs to be down-regulated for reducing viability of cancer cells. For two recently identified small molecule inhibitors, VER-155008 and 2-phenylethynesulfonamide (PES), which are proposed to target different sites in Hsp70s, we analyzed the molecular mode of action in vitro. We found that for significant reduction of viability of cancer cells simultaneous knockdown of heat-inducible Hsp70 (HSPA1) and constitutive Hsc70 (HSPA8) is necessary. The compound VER-155008, which binds to the nucleotide binding site of Hsp70, arrests the nucleotide binding domain (NBD) in a half-open conformation and thereby acts as ATP-competitive inhibitor that prevents allosteric control between NBD and substrate binding domain (SBD). Compound PES interacts with the SBD of Hsp70 in an unspecific, detergent-like fashion, under the conditions tested. None of the two inhibitors investigated was isoform-specific.Rainer SchlechtSebastian R ScholzHeike DahmenAnsgar WegenerChristian SirrenbergDjordje MusilJoerg BomkeHans-Michael EggenweilerMatthias P MayerBernd BukauPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 11, p e78443 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Rainer Schlecht Sebastian R Scholz Heike Dahmen Ansgar Wegener Christian Sirrenberg Djordje Musil Joerg Bomke Hans-Michael Eggenweiler Matthias P Mayer Bernd Bukau Functional analysis of Hsp70 inhibitors. |
description |
The molecular chaperones of the Hsp70 family have been recognized as targets for anti-cancer therapy. Since several paralogs of Hsp70 proteins exist in cytosol, endoplasmic reticulum and mitochondria, we investigated which isoform needs to be down-regulated for reducing viability of cancer cells. For two recently identified small molecule inhibitors, VER-155008 and 2-phenylethynesulfonamide (PES), which are proposed to target different sites in Hsp70s, we analyzed the molecular mode of action in vitro. We found that for significant reduction of viability of cancer cells simultaneous knockdown of heat-inducible Hsp70 (HSPA1) and constitutive Hsc70 (HSPA8) is necessary. The compound VER-155008, which binds to the nucleotide binding site of Hsp70, arrests the nucleotide binding domain (NBD) in a half-open conformation and thereby acts as ATP-competitive inhibitor that prevents allosteric control between NBD and substrate binding domain (SBD). Compound PES interacts with the SBD of Hsp70 in an unspecific, detergent-like fashion, under the conditions tested. None of the two inhibitors investigated was isoform-specific. |
format |
article |
author |
Rainer Schlecht Sebastian R Scholz Heike Dahmen Ansgar Wegener Christian Sirrenberg Djordje Musil Joerg Bomke Hans-Michael Eggenweiler Matthias P Mayer Bernd Bukau |
author_facet |
Rainer Schlecht Sebastian R Scholz Heike Dahmen Ansgar Wegener Christian Sirrenberg Djordje Musil Joerg Bomke Hans-Michael Eggenweiler Matthias P Mayer Bernd Bukau |
author_sort |
Rainer Schlecht |
title |
Functional analysis of Hsp70 inhibitors. |
title_short |
Functional analysis of Hsp70 inhibitors. |
title_full |
Functional analysis of Hsp70 inhibitors. |
title_fullStr |
Functional analysis of Hsp70 inhibitors. |
title_full_unstemmed |
Functional analysis of Hsp70 inhibitors. |
title_sort |
functional analysis of hsp70 inhibitors. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2013 |
url |
https://doaj.org/article/61d0e4e74a9e4efa87d2fb910f1f8022 |
work_keys_str_mv |
AT rainerschlecht functionalanalysisofhsp70inhibitors AT sebastianrscholz functionalanalysisofhsp70inhibitors AT heikedahmen functionalanalysisofhsp70inhibitors AT ansgarwegener functionalanalysisofhsp70inhibitors AT christiansirrenberg functionalanalysisofhsp70inhibitors AT djordjemusil functionalanalysisofhsp70inhibitors AT joergbomke functionalanalysisofhsp70inhibitors AT hansmichaeleggenweiler functionalanalysisofhsp70inhibitors AT matthiaspmayer functionalanalysisofhsp70inhibitors AT berndbukau functionalanalysisofhsp70inhibitors |
_version_ |
1718421323498127360 |